PER-1 type b-lactamases were screened among ceftazidime-resistant clinical isolates of Acinetobacter spp. and Pseudomonas aeruginosa. A total of 176 non-repetitive isolates (84 Acinetobacter spp. and 92 P. aeruginosa) were collected during a three month surveillance period. Isolates were obtained from seven intensive care units of seven university hospitals. All strains were screened for bla PER-1 alleles by PCR. Of the strains, 31% and 55.4% of Acinetobacter spp. and P. aeruginosa were positive for bla PER-1 type genes, respectively.
Introduction
Pseudomonas aeruginosa and Acinetobacter spp. are significant pathogens, particularly in intensive care units, in Turkey [1, 2] . These microorganisms exhibit resistance to a wide range of antibiotics by adjusting the expressions or functionality of some inherited structures, such as porins, pumps and PBPs [3] [4] [5] [6] . However, acquired b-lactamases have been reported very frequently among these species. IMP and VIM-type metallo b-lactamases and PER-1 and OXA-10 type ESBLs are the major b-lactamases identified. Class D enzymes with weak carbapenemase activity, on the other hand, are insidiously disseminating among these species [7] .
PER-1 was first detected in Turkey [8] and was found to be widespread among Acinetobacter spp. and P. aeruginosa [9] . Since then, PER1 has been discovered in other countries [10, 11] , and most recently found in northern Italy [12] and in Korea [13] .
b-Lactamases among clinical isolates of P. aeruginosa and Acinetobacter spp. from Turkish hospitals have not been widely studied since 1996. The current prevalence of PER-1 among pathogens in Turkey is unknown. In this epidemiological study, we surveyed PER-1 type blactamases among ceftazidime-resistant clinical isolates from seven intensive care units of seven tertiary care hospitals located in specific parts of Turkey.
Materials and methods

Bacterial strains and microbiological studies
Seven university hospitals from specific different parts of Turkey were asked to collect consecutive, non-replicate clinical isolates of P. aeruginosa and Acinetobacter spp. during the three months, April to June, in 2003.
The strains were re-identified in our laboratory by methods described elsewhere [9] and stored at À20°C until the study date.
MICs 
PCR, RAPD and sequence analysis
Genomic DNA for b-lactamase screening by PCR tests were extracted by simply by incubating dense bacterial suspensions at 95°C for 10 min and sedimenting the debris for 10 min at 12,000g. For random amplified polymorphic DNA (RAPD) analysis, however, a more concentrated and purified DNA was required. For this purpose, DNA was isolated by the lytic aid of guanidine thiocyanate lysis. The method is described elsewhere [9] . Briefly, bacteria were collected from overnight plate cultures in 0.1 M phosphate buffer (pH 7.2), pelleted and resuspended in 200 ml of TE buffer (10 mM Tris-HCl, 1 mM EDTA; pH 8.0). The cells were then lysed by adding 4 ml of lysis solution (5 M guanidine thiocyanate, 0.1 M EDTA (pH 8.0), 0.5% N-laurylsarcosine) and incubating at 60°C until the suspension was completely cleared. After 7.5 M ice-cold ammonium acetate (0.50 volume) was added and the solution was vortexed vigorously; DNAs were extracted once with chloroformisoamyl alcohol (24:1) and once with chloroform and later then precipitated with isopropanol (0.50 volume) at room temperature for 10 min. Precipitated chromosomal DNAs were collected and washed once with 70% ethanol and later air dried and dissolved in TE buffer overnight at 8°C.
PCR amplification was accomplished in 50 l1 volumes of 1 · PCR buffer with 1.5 mM MgCl 2 , 200 mM deoxynucleoside triphosphate mix, 1 mM primers each and 2 U of Taq polymerase (Fermentas, Litvania). The sequences and annealing temperature of primers are as follows: PER-1, PERA 5 0 -GTA GTT ACT GCC TCG ACG CT-3 0 and PERB 5 0 -TCA AAT TGA TAC GCA GTC TGA-3 0 (T m 57°C). PCR cycles consisted of 5 min denaturation at 95°C followed by 35 cycles of 1 min at the indicated annealing temperature, 2 min at 72°C and 30 s at 94°C, followed by 10 min of final incubation at 72°C. Products were separated on a 1.5 % agarose gel at a constant 120 V, stained with ethidium bromide and visualized on a UV lamp.
Genomic relatedness of strains was evaluated by random amplified polymorphic DNA analysis (RAPD) with ERIC primers, ERIC-1 R, 5 0 -AAG CTC CTG GGG ATT CA-3 0 and ERIC-2, 5 0 -AAG TAA GTG ACT GGG GTG AGC G-3 0 [14] . For RAPD analysis, the master mixture composition was the same as in the screening tests indicated above. But, the amplification cycles differed with as the initial denaturation followed by 25 cycles of 3 min at 39°C with an increase of 0.3°C every cycle, 2 min at 72°C and 1 min at 94°C and 30 cycles of 2 min 44°C, 3 min 72°C, and 1 min at 94°C. A final extension for 1 h at 72°C completed the procedure [14, 15] .
Both strands of PCR products were sequenced. After gel purification of the products, the sequencing was performed with the same primers used for amplification. The sequence analysis method was dye terminator cycle sequencing with the ABI Prism BigDye Terminator kit (Applied Biosystems, Foster City, Calif.). The assay was carried out according to the standard protocol. Data were collected on an ABI 377 automated fluorescence sequencer.
Chromatographs were analyzed and compared to the reference sequence with the aid of the freely distributed software ChromasPro (http://www.technelysium.com. au/ChromasPro.html).
Isoelectric focusing
b-Lactamases were extracted by freezing and thawing a dense suspension of bacteria in 0.1 N-(2-acetamido)-2-aminoethanesulfonic acid (ACES)-NaOH buffer (pH 7.0) as indicated elsewhere [9] . Crude b-lactamase extracts were analyzed with acrylamide gels with a pH range of 3-10 (Ampholyte sol. from Fluka), run at a constant power and visualized by overlaying a 1 mM suspension of nitrocefin (Oxoid). The details of this experiment are described elsewhere [9] . Results were interpreted relative to control enzymes, PER-1 (5.3), TEM-1 (pI 5.4), OXA-14 (pI 6.2) and SHV-1 (pI 7.6). SHV-1, TEM-1 and OXA-14 were gifts from David Livermore and PER-1 was from a previous study [16] . Table 1 shows MICs and the resistance percentages to the nine antimicrobial agents tested. Resistance to this panel of antibiotics in this collection was overall very high. Of note, however, was the difference in the resistance rates of imipenem and meropenem. Among this collection, imipenem resistance rates were higher.
Results
The distribution of bla PER-1 is shown in Table 2 . PER-1 type enzymes are found to be widespread and prevalent and almost evenly distributed among the contributing centers (data not shown).
Multiple antibiotic resistance phenotypes according to bla PER-1 occurrences are shown in Table 3 . This comparison demonstrated no significant differences in multiple antibiotic resistance phenotypes between bla PER-1 positive and negative strains.
Seven P. aeruginosa and seven Acinetobacter spp., one from each center, were randomly selected. RAPD analysis of seven Acinetobacter spp. and seven P. aeruginosa selected from different centers confirmed the multi-clonal spread of bla PER1 (Fig. 1) . PER genes from RAPD-typed strains were sequence-analyzed and, except for a few silent mutations, all were confirmed to be PER1.
Discussion
This study demonstrated that PER-1 is still a major resistance determinant of Acinetobacter spp. and P. aeruginosa in Turkish hospitals. In a similar survey in 1996, PER-1 type enzymes had been detected in 60% (33 of 55) and 38.4 % (40 of 104) of ceftazidime-resistant Acinetobacter spp. and P. aeruginosa, respectively [9] . In this study, the rate among Acinetobacter spp. was found to be significantly lower, at 31% (26 of 84), p < 0.05, compared to the survey of 1996; whereas the rate among P. aeruginosa is not significant. The figures in this study are somewhat different. Nevertheless, PER-1 is still widespread and highly prevalent.
Resistance to major antibiotics was found to be extremely high. The collection in this study represents only ceftazidime-resistant isolates. Since, ceftazidime ]; 2-3, resistant to ceftazidime plus two or three of the above mentioned antibiotic classes. resistance is extremely high in Turkish hospitals [17, 18] , the high resistance rates to major antibiotics found in this study is significant. On the other hand, PER1 was not significantly more related to multiple antibiotic resistance phenotypes. Moreover, among Acinetobacter spp. of this study, only one of 26 bla PER-1 positive isolates was resistant to imipenem; whereas, of PER-1 negative isolates, 21 of 58 were resistant to imipenem (data not shown). PER-1 type enzyme positive strains, in other words, are not more resistant than others. However, independent of antibiotic resistance, PER-1 was found to be significantly related to adverse clinical outcomes in Turkish hospitals [19] . This study documented that PER-1 is still a significant health problem in Turkey as it is in some other countries, and deserves merits more attention.
